In this respect, strategies focused on circulating PCSK9 rather than on brain PCSK9 might be more powerful to fight AD since, thanks to their hypocholesterolemic activities, they could prevent BBB disruption, and in the end neurodegeneration. This evidence concerns the gene PCSK9 and Alzheimer disease.